Home » Topics » Regulatory

Regulatory
RSS

FDA approves abacavir for treatment of HIV-1 infection

Dec. 21, 1998

Expanded indications, new formulation of Lamictal now available in U.S.

Dec. 21, 1998

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

Eisai launches new formulation of antiarrhythmic drug in Japan

Dec. 16, 1998

FDA approves expanded indication for CytoGam

Dec. 14, 1998

Philippines is the first market for lamivudine as anti-HBV agent

Dec. 14, 1998

Schering-Plough files NDA for next-generation corticosteroid

Dec. 14, 1998

FDA approves Rebetron combination therapy for previously untreated HCV patients

Dec. 11, 1998

FDA approves Sandostatin LAR once-monthly depot formulation

Dec. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...